Loading...
More from the Pipeline of Clinical Research on SELECTED SYSTEMIC THERAPIES FOR ATOPIC DERMATITIS
Many systemic therapies are under development for atopic dermatitis, many of which are injectable monoclonal antibodies that inhibit specific pathways involved in the pathogenesis of the disease. Most are currently under development, however, there are preliminary studies with subcutaneous omalizuma...
Na minha lista:
| Udgivet i: | J Clin Aesthet Dermatol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Matrix Medical Communications
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6561716/ https://ncbi.nlm.nih.gov/pubmed/31320978 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|